REFRACTORY TUMOR

Clinical trials for REFRACTORY TUMOR explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY TUMOR trials appear

Sign up with your email to follow new studies for REFRACTORY TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Experimental drug DCR-STAT3 tested in patients with stubborn cancers

Disease control Completed

This early-stage trial tested an experimental drug called DCR-STAT3 in 26 adults with solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. Researchers gave increasing doses to find the best an…

Matched conditions: REFRACTORY TUMOR

Phase: PHASE1 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC

REFRACTORY TUMOR

Get alerted when new REFRACTORY TUMOR trials appear

Experimental drug DCR-STAT3 tested in patients with stubborn cancers